FINAL DEADLINE ALERT: Faruqi & Faruqi Reminds Telix Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 9, 2026
Telix Pharmaceuticals LtdTelix Pharmaceuticals Ltd(US:TLX) Businesswire·2026-01-09 15:10

Core Viewpoint - Telix Pharmaceuticals Limited is under investigation for potential claims related to a federal securities class action, with a deadline for investors to seek lead plaintiff status set for January 9, 2026 [1] Group 1 - Faruqi & Faruqi, LLP, a prominent national securities law firm, is leading the investigation into Telix Pharmaceuticals [1] - The investigation pertains to potential claims against Telix Pharmaceuticals Limited, which trades on NASDAQ under the ticker TLX [1]